Casi pharmaceuticals, inc. (CASI)
Balance Sheet / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Dec'10
ASSETS
Current assets:
Cash and cash equivalents

53,885

53,621

63,241

70,251

99,733

84,205

98,867

66,215

49,887

43,489

21,640

23,360

25,528

27,092

24,137

18,534

13,944

5,131

6,423

7,953

9,459

10,669

11,817

13,079

14,199

15,131

15,871

17,222

18,270

8,049

8,812

10,058

11,345

1,080

1,986

3,800

4,885

Investment in equity securities, at fair value

610

625

557

716

957

912

1,165

1,220

1,322

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

25

Accounts receivable, net of $0 allowance for doubtful accounts

1,872

1,293

2,643

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

0

23

23

23

-

-

-

0

0

0

0

669

0

0

0

1,932

-

-

2,750

Inventories

2,009

4,542

2,565

672

-

283

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses and other

1,420

1,420

4,356

8,968

6,993

7,165

1,343

977

876

322

441

250

335

355

401

230

319

438

404

308

431

328

336

136

280

279

316

233

138

189

238

143

631

193

224

174

265

Total current assets

59,796

61,501

73,362

80,609

107,684

92,565

101,375

68,414

52,085

43,812

22,081

23,611

25,864

27,448

24,538

18,764

14,263

5,569

6,828

8,286

9,913

11,021

12,153

13,216

14,480

15,411

16,187

17,456

18,408

8,908

9,050

10,202

11,977

3,207

2,210

3,975

7,927

Property and equipment, net

826

985

1,374

1,335

1,902

1,751

1,594

1,617

1,200

1,046

566

448

244

229

184

168

222

218

234

245

246

261

230

240

113

78

56

60

61

52

21

15

20

24

28

85

104

Intangible assets, net

16,289

16,895

17,268

18,191

18,349

18,785

17,110

17,457

17,804

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Long-term investments

14,038

14,038

14,038

13,897

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Right of use assets

8,255

8,708

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other assets

281

504

3,028

3,056

3,123

310

228

221

70

242

68

72

72

34

34

34

38

38

38

46

26

26

26

26

26

17

17

21

17

17

17

17

4

4

4

4

4

Total assets

99,485

102,631

109,070

117,090

131,060

113,411

120,308

87,710

71,162

45,100

22,716

24,132

26,181

27,712

24,756

18,967

14,524

5,826

7,101

8,578

10,186

11,309

12,410

13,482

14,619

15,507

16,262

17,538

18,487

8,977

9,089

10,234

12,001

3,235

2,243

4,065

8,037

LIABILITIES, REDEEMABLE NONCONTROLLING INTEREST AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable

5,452

5,113

4,827

2,321

1,383

968

1,740

2,089

1,581

2,087

1,203

1,183

1,119

1,064

918

945

783

884

801

969

994

754

600

573

591

402

352

599

648

504

484

576

743

453

491

980

1,351

Payable to related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

86

-

-

-

0

-

-

-

Payable to related party

-

-

-

-

-

-

2,880

0

0

2,228

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

55

-

-

-

-

-

-

Accrued liabilities

2,089

2,834

2,121

2,361

2,120

1,406

800

544

462

745

302

309

199

250

161

160

158

169

169

181

175

164

163

169

164

162

149

150

145

151

185

367

401

250

268

300

595

Note payable, net of discount

-

-

0

1,499

1,499

1,499

1,499

-

-

0

1,496

1,495

1,493

-

1,485

1,478

1,471

-

-

1,435

1,412

-

-

-

-

-

-

-

-

-

-

-

8,436

-

-

-

-

Loan payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

757

Total current liabilities

7,541

7,947

6,948

6,182

5,003

3,873

6,920

2,634

2,044

5,062

3,003

2,988

2,812

1,315

2,566

2,585

2,413

1,053

970

2,586

2,582

919

764

743

755

565

501

749

794

742

726

944

9,582

704

760

1,281

2,703

Note payable, net of discount

-

-

-

-

-

-

0

1,499

1,498

1,498

0

0

0

1,491

0

0

0

1,464

1,457

0

0

1,390

1,367

-

-

0

-

-

-

-

-

-

-

-

-

-

-

Other liabilities

704

1,019

1,292

1,633

1,843

74

66

55

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Contingent rights derivative liability

-

-

-

-

-

-

-

-

-

-

4,134

4,118

4,129

4,122

6,167

6,358

7,474

9,395

9,405

9,441

9,429

9,422

9,441

-

-

0

-

-

-

-

-

-

-

-

-

-

-

Total liabilities

8,245

8,966

8,240

7,815

6,847

3,947

6,987

4,188

3,542

6,560

7,138

7,106

6,941

6,929

8,733

8,943

9,888

11,913

11,834

12,027

12,012

11,731

11,572

-

-

565

-

-

-

-

-

-

-

-

-

-

-

Commitments and contingencies (Note 16)

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Redeemable noncontrolling interest, at redemption value (Note 8)

20,878

20,670

20,459

20,236

20,016

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Stockholders' equity:
Preferred stock, $1.00 par value: 5,000,000 shares authorized and 0 shares issued and outstanding

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

3,350

3,350

3,350

3,350

3,350

Common stock, $0.01 par value: 250,000,000 shares authorized at March 31, 2020 and December 31, 2019; 100,994,374 shares and 97,851,243 shares issued at March 31, 2020 and December 31, 2019, respectively; 100,914,829 shares and 97,771,698 shares outstanding at March 31, 2020 and December 31, 2019, respectively

1,010

979

964

957

957

954

934

865

797

699

602

602

602

602

495

475

426

325

325

325

325

325

325

271

271

271

271

271

271

225

225

225

122

122

122

116

115

Common stock to be issued for 186,567 shares

-

-

-

-

-

-

1,000

56

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Common stock to be issued

-

-

-

-

-

-

-

-

-

-

-

-

-

-

6,274

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Common stock subscribed

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

964

-

Additional paid-in capital

612,972

606,686

603,378

600,569

599,301

596,712

590,322

552,093

529,389

498,577

470,663

470,497

470,303

470,147

456,545

455,147

446,516

434,099

433,752

433,430

432,958

432,558

432,221

422,639

422,147

421,775

421,285

420,871

419,923

409,374

409,142

408,881

388,301

385,879

385,835

384,869

384,130

Treasury stock, at cost: 79,545 shares held at March 31, 2020 and December 31, 2019

8,034

8,034

8,034

8,034

8,034

8,034

8,034

8,034

8,034

8,034

8,034

8,034

8,034

8,034

8,034

8,034

8,034

8,034

8,034

8,034

8,034

8,034

8,034

8,034

8,034

8,034

8,034

8,034

8,034

8,034

8,034

8,034

8,034

8,034

8,034

8,034

8,034

Accumulated other comprehensive loss

-3,554

-2,728

-3,863

-2,027

-914

-1,227

-1,224

-539

527

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accumulated deficit

-532,032

-523,908

-512,074

-502,428

-487,114

-478,941

-469,676

-460,920

-455,060

-452,702

-447,654

-446,040

-443,632

-441,931

-439,258

-437,564

-434,272

-432,478

-430,775

-429,170

-427,075

-425,271

-423,675

-402,136

-400,520

-399,069

-397,761

-396,318

-394,467

-393,331

-392,970

-391,783

-381,319

-378,786

-379,790

-378,482

-374,227

Total stockholders' equity

70,362

72,995

80,371

89,037

104,196

109,464

113,321

83,522

67,619

38,540

15,577

17,025

19,239

20,783

16,022

10,023

4,636

-6,087

-4,732

-3,448

-1,826

-422

837

12,739

13,863

14,942

15,760

16,788

17,692

8,235

8,363

9,290

2,419

2,531

1,483

2,784

5,333

Total liabilities, redeemable noncontrolling interest and stockholders' equity

99,485

102,631

109,070

117,090

131,060

113,411

120,308

87,710

71,162

45,100

22,716

24,132

26,181

27,712

24,756

18,967

14,524

5,826

7,101

8,578

10,186

11,309

12,410

13,482

14,619

15,507

16,262

17,538

18,487

8,977

9,089

10,234

12,001

3,235

2,243

4,065

8,037